A gene chip kit for detecting drug-resistant genes of Gram-negative bacteria
A Gram-negative, drug-resistant gene technology, applied in the field of nucleic acid amplification, can solve the problems of cumbersome operation, low throughput, and slow report results
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0061] Embodiment 1, preparation and use thereof for detecting the kit of Gram-negative bacterial drug resistance gene
[0062] 1. Assembly and preparation of kits for detecting drug resistance genes of Gram-negative bacteria
[0063] 1. Primers and hybridization probes designed for 10 Gram-negative bacterial drug resistance genes
[0064] The specific sequences of primers and single-stranded hybridization probes designed for 10 Gram-negative bacterial drug resistance genes are shown in Table 1 and Table 2.
[0065] Table 1 Primers designed for 10 Gram-negative bacterial drug-resistant genes
[0066]
[0067]
[0068] Table 2 Single-stranded hybridization probes designed for 10 Gram-negative bacterial drug-resistant genes
[0069] Numbering
detection gene
probe name
Sequence (5'-3')
1
bla DHA-1
EF406115.1
DHA-574
TTGCTGACTGCACGGATCCT (sequence 21)
2
bla OXA-23
JN665073.1
OXA23-139
CCCGAGTC...
Embodiment 2
[0091] Embodiment 2, the specificity and the sensitivity determination of the kit for detecting drug resistance gene of Gram-negative bacteria
[0092] 1. Preparation of reference DNA plasmid
[0093] 1. Contains bla DHA-1 Construction of plasmids for gene target fragments
[0094] will bla DHA-1 The DNA fragment shown at positions 1-1113 of the gene (GenBank: EF406115.1, update: 2007-8-17) was ligated to the pGEM-T Easy Vector vector (promega company product) to obtain the recombinant plasmid ZL-DHA-1. and verified by sequencing.
[0095] 2. Contains bla OXA-23 Construction of plasmids for gene target fragments
[0096] will bla OXA-23 The DNA fragment shown at positions 97-899 of the gene (GenBank: JN665073.1, update: 2011-11-7) was ligated to the pGEM-T Easy Vector vector to obtain the recombinant plasmid ZL-OXA-23. and verified by sequencing.
[0097] 3. Contains bla OXA-24 Construction of plasmids for gene target fragments
[0098] will bla OXA-24 The DNA fragm...
Embodiment 3
[0119] Embodiment 3, the detection of actual clinical sample
[0120] 1. Types of clinical samples
[0121] The clinical samples used in this example came from viscous pus from human wounds collected by Peking University People's Hospital (based on the principle of voluntariness of the collectors), a total of three samples.
[0122] 2. Extraction of DNA samples from clinical samples
[0123] 1. Take 1-3mL of clinical samples from step 1;
[0124] 2. Add 4 times the volume of 4% (4g / 100mL) NaOH, shake well, and place at room temperature for 30 minutes to liquefy;
[0125] 3. Take 0.5mL of liquefied pus and 0.5ml of 4% (4g / 100mL) NaOH, room temperature, 10min;
[0126] 4. Centrifuge at 12 000 rpm for 15 minutes;
[0127] 5. Discard the supernatant, add 1 mL of sterile saline, mix well, and centrifuge at 12 000 rpm for 5 min;
[0128] 6. Discard the supernatant, and precipitate for DNA extraction;
[0129] 7. Add 50 μL of nucleic acid extraction solution (product of Boao Bi...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com